28 related articles for article (PubMed ID: 28792693)
21. C-reactive protein but not hepcidin, NGAL and transferrin determines the ESA resistance in hemodialysis patients.
Yılmaz I; Ozkok A; Kostek O; Kolukısa A; Duran I; Odabaş AR; Kemal Işman F; Işbilen Başok B
Ren Fail; 2016; 38(1):89-95. PubMed ID: 26539647
[TBL] [Abstract][Full Text] [Related]
22. Serum Hepcidin Levels in Multiple Myeloma.
Victor M; Evgeniy H; Gergana T; Julia P; Vasil V; Borislav M; Ivo B; Zlatina G; Kamen T
Clin Lab; 2017 Jul; 63(7):1273-1277. PubMed ID: 28792693
[TBL] [Abstract][Full Text] [Related]
23. Iron in multiple myeloma.
VanderWall K; Daniels-Wells TR; Penichet M; Lichtenstein A
Crit Rev Oncog; 2013; 18(5):449-61. PubMed ID: 23879589
[TBL] [Abstract][Full Text] [Related]
24. New Biomarkers of Ferric Management in Multiple Myeloma and Kidney Disease-Associated Anemia.
Banaszkiewicz M; Małyszko J; Vesole DH; Woziwodzka K; Jurczyszyn A; Żórawski M; Krzanowski M; Małyszko J; Batko K; Kuźniewski M; Krzanowska K
J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31683939
[TBL] [Abstract][Full Text] [Related]
25.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
